Universities sometimes turn small, uncontrolled clinical cohorts into striking causal headlines through press offices and selective phrasing. That process can amplify weak observational findings into perceived proof that shapes public debate and policy.
— If academic PR regularizes overstated causal claims, policymakers, clinicians, and the public will make decisions on a distorted evidence base.
Kelsey Piper
2026.04.17
85% relevant
The article documents how a prominent Stanford education researcher (Jo Boaler) promoted weak, poorly documented studies that influenced Bay Area school policy — a direct example of universities or their faculty promoting low‑quality evidence with real policy consequences.
Michael Inzlicht
2026.04.01
85% relevant
The article documents how a sensational, poorly‑verified account (38 witnesses watching Kitty Genovese being murdered) became the foundational anecdote for Darley and Latané’s bystander‑effect research and broader public narratives—an example of academic and media institutions amplifying a weak or inaccurate empirical claim.
Cremieux
2026.03.25
80% relevant
This article exemplifies the pattern of researchers and institutions publicizing suggestive between‑person findings as stronger evidence than warranted: Cremieux critiques Nagata et al.'s Lancet‑linked ABCD analysis and reanalyses the same data with within‑person and sibling fixed‑effects to test the causal claim, showing the institutional tendency to elevate weak causal inference into headlines.
2026.03.05
100% relevant
University of Washington press release and quoted study authors framed Tordoff et al.'s Seattle Children’s clinic cohort as showing 'caused rates... to plummet' despite observational limitations discussed in the article.
2025.05.25
85% relevant
This case exemplifies how high‑profile academic claims can unravel: Gino’s celebrated work on honesty was later challenged by Data Colada and a Harvard investigation found manipulated data in multiple studies, illustrating the risk that institutions and media overpromote weak or flawed findings until independent scrutiny forces correction.
2023.07.18
60% relevant
Nature highlights high‑profile cases and systemic weaknesses (poor data sharing, weak oversight) that let flawed trial results reach journals and press — feeding institutional promotion of tentative or false findings and matching the idea that institutions can oversell weak evidence.